ASRA Coags is a medical reference app for anesthesiologists and pain specialists, providing searchable anticoagulation guidelines and procedure-based drug recommendations on iOS and Android.
The App DNA
What makes this app unique?
Medical professionals hire this app to reduce clinical decision-making time during high-pressure procedures, using society-sanctioned data to ensure patient safety.
For Anesthesiologists, pain medicine specialists, and healthcare providers performing regional anesthesia or interventional pain procedures.
Key features
Searchable database of drug-specific recommendations for regional anesthesia and interventional pain procedures
Drug recommendations filtered by block type or procedure risk level
In-app access to the full 2025 regional and 2018 interventional pain guideline documents
How much does it cost?
Subscription model anchored at $6.99/year, utilizing the app as a membership retention tool for the professional society.
Velocity
Steady developmentShow more...
5 versions in history. Development pace: steady.
Who built it?
American Society of Regional Anesthesia and Pain Medicine
3 apps tracked · Medical
ASRA Pain Medicine App
ASRA TimeoutUser Sentiment
What do users think recently?
The recent review mood reads upset. Users appreciate clinical utility of the perioperative anticoagulant scheduling tool remains highly valued by medical professionals.
How are ratings & reviews evolving?
What users say, by theme
- Clinical utility of the perioperative anticoagulant scheduling tool remains highly valued by medical professionals
- Forced subscription model revokes lifetime access previously purchased by long-term medical professional users
49 of 49 recent reviews analyzed · high confidence · Upset overall
Read the full review analysisUnlock 1 more frustration theme and 1 user request, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for ASRA Coags
How's the Medical market?
ASRA Coags holds a niche position in the medical category, but its 1.27-star rating across 578 total ratings indicates severe user dissatisfaction following the recent subscription transition. The lack of competitive feature parity with mega-apps like Vargo Anesthesia leaves the app vulnerable to churn.
Read the market outlookThe rivals identified
By Vargo Anesthesia Inc
Dominates the anesthesia niche with a comprehensive, high-frequency update cycle that dwarfs specialized tools.
- Aggressive release cadence of nine updates in six months ensures constant feature evolution and stability.
- Consolidates multiple anesthesia tools into one mega-app, creating a high barrier to entry for single-purpose apps.
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for ASRA Coags
Where is it heading?
The medical reference market is consolidating around high-frequency, multi-tool apps that prioritize stability and integration. ASRA Coags is currently exposed due to its infrequent update cycle and the reputational damage caused by the subscription transition, which will likely lead to further user churn unless the legacy access issue is resolved.
- The transition to a subscription model has triggered a severe backlash from the professional medical user base, which is driving users to abandon the app.
- Technical instability and application crashes reported following the transition to the new build are eroding the daily active habit.
The SWOT
- Society-sanctioned clinical standards function as a primary distribution moat for professional practitioners.
- Procedure-based search reduces clinical decision-making time, driving daily utility.
- Integration of wearable-based clinical alerts could provide a high-utility differentiator.
- B2B partnerships with hospital systems could bypass individual subscription friction.
Next best moves
Grandfather legacy users into the current subscription tier because the lack of access for prior purchasers is the #1 sentiment driver → restore brand trust
+ 1 more prioritized moveThe counter-intuitive read
The app's primary risk is not the subscription price…
Read the full takeFeature gaps
Integrated clinical calculators (available in Anesthesia Central but absent here) +1
Since the last report: The app's transition to a mandatory subscription model without legacy support has caused a severe decline in user sentiment and brand trust.
Bottom line
ASRA Coags retains high clinical value, but the aggressive subscription pivot has alienated its core professional base, so the PM must prioritize grandfathering legacy users to halt the rating collapse.
Unlock 2 critical frictions, 2 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeReport last updated